Colorectal cancer patients remain a large but underserved population with desperate need for significant improvements in outcomes, along with reduction in toxicity and lessening of impact in quality of life. Pending breakthroughs in new technology, optimization of existing infrastructure and techniques will best serve our patients. This special edition focusses on areas of highest need, where treatment optimisation may translate into better outcomes for patients with colorectal cancer.
Role of imaging and synoptic MRI reporting in determining optimal management paradigm for rectal cancer: a narrative review
Stage III colon cancer: is neoadjuvant chemotherapy ready for prime time?—A narrative review of neoadjuvant chemotherapy for colon cancer
Current management and controversies in management of T4 cancers of the colon—a narrative review of the literature
The series “Colorectal Cancer” was commissioned by the editorial office, Digestive Medicine Research without any sponsorship or funding. Eva Segelov is serving as the unpaid Guest Editor for the series.